WHO ICTRP trial
A randomized, controlled trial to evaluate the clinical efficacy and safety of…
ChiCTR2000040220 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000040220 |
|---|---|
| Public title | A randomized, controlled trial to evaluate the clinical efficacy and safety of umbilical cord mesenchymal stem cells in the treatment of moderate to severe Crohn's disease |
| Scientific title | A randomized, controlled trial to evaluate the clinical efficacy and safety of umbilical cord mesenchymal stem cells in the treatment of moderate to severe Crohn's disease |
| Primary sponsor | Shanghai East Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | Crohn's disease |
| Interventions | MSC combination therapy group:MSCs were injected intravenously and submucosal;Solution control group:Intravenous infusion and submucosal injection of the solvent used to dissolve MSCs;Drug control group:Common drug therapy |
| Registration date | Nov 25, 2020 |
| Target size | MSC combination therapy group:20;Solution control group:20;Drug control group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: